Obermatt
See Similar Stocks →

Corbion

AEX:CRBN · NL0010583399
ChemicalsMedium

360

65
EV / EBIT52
Price / Owner Earnings52
Owner Earnings Yield72
Dividend Yield89
Price/Sales60
EV / Gross Profit56
Price/Book56
Return on Capital56
Cash Return on Capital57
Return on Equity67
EBIT Margin47
Gross Profitability67
Cash Conversion79
Accruals64
Owner Earnings Margin53
Sales growth33
Profit Growth42
Long-Term EPS Growth37
Owner Earnings Growth70
Reinvestment73
Price momentum53
Debt load40
Refinancing68
Debt Payback23
Liquidity65
Analyst ratings59
Opinion Changes50
Price Target Upside56
Market mood90
Value Creation12/20creating some value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Corbion clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.

Profile

CountryNetherlands
IndustryChemicals
SizeMedium
TypePublic Company
ExchangeENXTAM
Founded1919
Employees1,842
Websitecorbion.com
ISINNL0010583399
Last UpdateApr 2, 2026
Indices
Sound Pay Practices (Europe)
Themes
Bio-based and Renewable MaterialsCleanTechBiofuelAnimal FeedNutraceuticalFood Processing

Description

Corbion N.V. provides lactic acid and lactic acid derivatives, other ferment, functional enzyme blends, minerals, vitamins, and algae ingredients. Business Segments The company operates through Sustainable Food Solutions, Lactic Acid & Specialties,…

Analysis

Middle-of-the-road

Corbion N.V. sits in the middle of our grid: average quality, average price, no obvious signal in either direction.

On valuation, the picture is attractive. The owner-earnings multiple stands at 14.9×; owner earnings: the cash an owner could take out each year.

Growth is moderate; the safety picture is stretched. The company scores 12/20 on our value-creation score: creating some value.

No flags apply to this company at this time: accounts, balance sheet, and cash quality all pass. A clean bill of health is meaningful, not just the absence of a warning. This analysis describes numbers; it is not investment advice.

360° rank · history

1007550250
94
2023202420252026

All-time high

94

Jun 2026

All-time low

1

Jan 2024

Average rank

44

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
60
44
64
43
Price/Earnings
65
50
43
24
Price/Book
56
42
42
22
Dividend Yield
89
65
53
34
Value (overall)
84
54
54
23

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Corbion with its peers
Nestlé India
NSI:NESTLEIND
58
CountrySwitzerland
IndustryFood Products
SizeLarge
Full Stock Analysis →
ABF
LSE:ABF
39
CountryUK
IndustryFood Products
SizeX-Large
Full Stock Analysis →
BRAIN Biotech
GER:BNN
40
CountryGermany
IndustryChemicals
SizeSmall
Full Stock Analysis →
Treatt
LSE:TET
32
CountryUK
IndustryChemicals
SizeSmall
Full Stock Analysis →
Givaudan
VTX:GIVN
45
CountrySwitzerland
IndustryChemicals
SizeSmall
Full Stock Analysis →
ICL Group
TLV:ICL
23
CountryIsrael
IndustryChemicals
SizeLarge
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →